Variant report

Variant	nsv468966
Chromosome Location	chr12:1907853-1933553
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:845)
CpG islands
(count:733)
Chromatin interactive
region (count:28)
LncRNA
region (count:15)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:845 , 50 per page) page: 1 2 3 4 5 6 7 ... 17

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr12:1913813-1913883	K562	blood:	n/a	n/a
2	ARID3A	chr12:1922073-1922329	HepG2	liver:	n/a	n/a
3	ARID3A	chr12:1925448-1925599	HepG2	liver:	n/a	n/a
4	ARID3A	chr12:1920868-1921315	HepG2	liver:	n/a	n/a
5	ATF1	chr12:1921987-1922475	K562	blood:	n/a	n/a
6	ATF3	chr12:1922183-1922369	K562	blood:	n/a	n/a
7	ATF3	chr12:1922071-1922413	K562	blood:	n/a	n/a
8	BACH1	chr12:1929552-1929694	H1-hESC	embryonic stem cell:	n/a	n/a
9	BCL3	chr12:1925781-1926303	GM12878	blood:	n/a	n/a
10	BCL3	chr12:1925752-1926306	GM12878	blood:	n/a	n/a
11	BHLHE40	chr12:1913694-1914096	K562	blood:	n/a	n/a
12	BHLHE40	chr12:1920726-1921486	HepG2	liver:	n/a	chr12:1921279-1921288 chr12:1921277-1921290 chr12:1921273-1921294 chr12:1921280-1921289 chr12:1921279-1921288
13	BHLHE40	chr12:1931012-1931206	K562	blood:	n/a	n/a
14	BHLHE40	chr12:1921026-1921446	K562	blood:	n/a	chr12:1921279-1921288 chr12:1921277-1921290 chr12:1921273-1921294 chr12:1921280-1921289 chr12:1921279-1921288
15	BHLHE40	chr12:1916317-1916484	HepG2	liver:	n/a	n/a
16	BHLHE40	chr12:1925707-1926113	K562	blood:	n/a	n/a
17	BHLHE40	chr12:1922021-1922463	HepG2	liver:	n/a	n/a
18	BHLHE40	chr12:1921907-1922486	K562	blood:	n/a	n/a
19	BHLHE40	chr12:1913620-1914053	GM12878	blood:	n/a	n/a
20	BHLHE40	chr12:1919012-1919508	K562	blood:	n/a	n/a
21	BHLHE40	chr12:1919741-1919978	K562	blood:	n/a	n/a
22	BHLHE40	chr12:1931087-1931195	GM12878	blood:	n/a	n/a
23	CBX3	chr12:1913667-1914061	K562	blood:	n/a	n/a
24	CBX3	chr12:1913660-1914114	K562	blood:	n/a	n/a
25	CEBPB	chr12:1922117-1922500	HepG2	liver:	n/a	n/a
26	CEBPB	chr12:1925068-1925245	K562	blood:	n/a	chr12:1925179-1925190
27	CEBPB	chr12:1913749-1913804	K562	blood:	n/a	n/a
28	CEBPB	chr12:1925092-1925284	HepG2	liver:	n/a	chr12:1925179-1925190
29	CEBPB	chr12:1921998-1922512	K562	blood:	n/a	n/a
30	CEBPB	chr12:1925053-1925265	IMR90	lung:	n/a	chr12:1925179-1925190
31	CEBPB	chr12:1909940-1910146	HepG2	liver:	n/a	n/a
32	CEBPB	chr12:1912790-1913012	HepG2	liver:	n/a	chr12:1912889-1912902 chr12:1912889-1912900
33	CEBPB	chr12:1922122-1922532	Hela-S3	cervix:	n/a	n/a
34	CEBPB	chr12:1922125-1922504	HepG2	liver:	n/a	n/a
35	CEBPB	chr12:1922183-1922411	HepG2	liver:	n/a	n/a
36	CEBPB	chr12:1922052-1922507	K562	blood:	n/a	n/a
37	CEBPB	chr12:1922101-1922448	K562	blood:	n/a	n/a
38	CEBPB	chr12:1922143-1922487	IMR90	lung:	n/a	n/a
39	CEBPB	chr12:1922099-1922524	MCF-7	breast:	n/a	n/a
40	CEBPB	chr12:1909824-1910094	Hela-S3	cervix:	n/a	n/a
41	CEBPB	chr12:1922173-1922460	A549	lung:	n/a	n/a
42	CEBPB	chr12:1909882-1910134	K562	blood:	n/a	n/a
43	CEBPB	chr12:1925008-1925361	HepG2	liver:	n/a	chr12:1925179-1925190
44	CEBPB	chr12:1922087-1922482	MCF-7	breast:	n/a	n/a
45	CEBPB	chr12:1922078-1922495	HepG2	liver:	n/a	n/a
46	CEBPD	chr12:1922032-1922560	K562	blood:	n/a	chr12:1922313-1922324
47	CHD2	chr12:1929523-1929547	H1-hESC	embryonic stem cell:	n/a	n/a
48	CHD2	chr12:1913686-1913978	K562	blood:	n/a	n/a
49	CHD2	chr12:1913665-1914018	GM12878	blood:	n/a	n/a
50	CHD2	chr12:1909792-1909992	HepG2	liver:	n/a	n/a

(count:733 , 50 per page) page: 1 2 3 4 5 6 7 ... 15

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr12:1922058-1922108	HCF	heart:	n/a
2	chr12:1922058-1922108	HCF	heart:	n/a
3	chr12:1908303-1908353	PrEC	prostate:	n/a
4	chr12:1921115-1921165	NHDF-neo	bronchial:	n/a
5	chr12:1908303-1908353	HEEpiC	esophagus:	n/a
6	chr12:1922067-1922117	K562	blood:	n/a
7	chr12:1928481-1928531	BJ	skin:	n/a
8	chr12:1929588-1929638	GM12878	blood:	n/a
9	chr12:1928481-1928531	HEK293	kidney:	embryo
10	chr12:1929348-1929398	HEEpiC	esophagus:	n/a
11	chr12:1929265-1929315	GM12892	blood:	n/a
12	chr12:1929588-1929638	GM19239	blood:	n/a
13	chr12:1908303-1908353	NB4	blood:	n/a
14	chr12:1928481-1928531	AG04449	skin:	fetal
15	chr12:1929551-1929601	HL-60	blood:	n/a
16	chr12:1928689-1928739	GM12878	blood:	n/a
17	chr12:1929551-1929601	ovcar-3	ovarian:	n/a
18	chr12:1908303-1908353	HCM	heart:	n/a
19	chr12:1929348-1929398	ECC-1	luminal epithelium:	n/a
20	chr12:1928481-1928531	HUVEC	blood vessel:	n/a
21	chr12:1908303-1908353	IMR90	lung:	fetal
22	chr12:1929265-1929315	AG09319	gingival:	n/a
23	chr12:1930326-1930376	K562	blood:	n/a
24	chr12:1921115-1921165	ProgFib	skin:	n/a
25	chr12:1922058-1922108	HUVEC	blood vessel:	n/a
26	chr12:1921115-1921165	GM12892	blood:	n/a
27	chr12:1930326-1930376	H1-hESC	embryonic stem cell:	embryo
28	chr12:1921115-1921165	HL-60	blood:	n/a
29	chr12:1908303-1908353	HRCEpiC	kidney:	n/a
30	chr12:1929348-1929398	PFSK-1	brain:	n/a
31	chr12:1928481-1928531	K562	blood:	n/a
32	chr12:1929265-1929315	HUVEC	blood vessel:	n/a
33	chr12:1928481-1928531	NB4	blood:	n/a
34	chr12:1929551-1929601	SK-N-MC	brain:	n/a
35	chr12:1929551-1929601	H1-hESC	embryonic stem cell:	embryo
36	chr12:1921115-1921165	AG09309	skin:	n/a
37	chr12:1921115-1921165	HRCEpiC	kidney:	n/a
38	chr12:1929551-1929601	LNCaP	prostate:	n/a
39	chr12:1929348-1929398	SAEC	small airway:	n/a
40	chr12:1929348-1929398	SKMC	muscle:	n/a
41	chr12:1928481-1928531	ECC-1	luminal epithelium:	n/a
42	chr12:1922067-1922117	PrEC	prostate:	n/a
43	chr12:1928689-1928739	HepG2	liver:	n/a
44	chr12:1930326-1930376	BJ	skin:	n/a
45	chr12:1929551-1929601	GM12878	blood:	n/a
46	chr12:1909916-1909966	HCPEpiC	choroid plexus:	n/a
47	chr12:1929348-1929398	HAEpiC	amniotic membrane:	n/a
48	chr12:1930326-1930376	HRCEpiC	kidney:	n/a
49	chr12:1922067-1922117	SK-N-MC	brain:	n/a
50	chr12:1930326-1930376	HPAEpiC	pulmonary alveolar:	n/a

(count:28 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr11:62647795..62648738-chr12:1919373..1920206,2	NB4	blood:
2	chr12:1690585..1692934-chr12:1917638..1919676,2	K562	blood:
3	chr12:1905522..1910417-chr12:1912711..1915784,4	K562	blood:
4	chr12:1909928..1910790-chr12:2048924..2049519,2	K562	blood:
5	chr12:1923066..1926339-chr12:1927484..1932040,5	MCF-7	breast:
6	chr12:1923170..1924049-chr12:2041180..2042060,3	MCF-7	breast:
7	chr12:1908657..1911491-chr12:1913622..1915388,2	MCF-7	breast:
8	chr12:1912567..1914410-chr12:1917472..1919007,2	K562	blood:
9	chr12:1923170..1923815-chr12:2041317..2042058,2	MCF-7	breast:
10	chr12:1912567..1914410-chr12:1917472..1919007,2	K562	blood:
11	chr12:1932447..1935067-chr12:1939828..1942115,3	MCF-7	breast:
12	chr12:1915615..1917986-chr12:1924786..1926838,2	K562	blood:
13	chr12:1912567..1917043-chr12:1917472..1921043,5	K562	blood:
14	chr12:1921269..1923557-chr12:2112437..2115050,2	MCF-7	breast:
15	chr12:1933541..1935951-chr12:1940567..1942424,2	K562	blood:
16	chr12:1918012..1920353-chr12:1939627..1941633,2	MCF-7	breast:
17	chr12:1910081..1912246-chr12:1949040..1950547,2	K562	blood:
18	chr12:1910843..1912522-chr12:1945003..1947651,2	MCF-7	breast:
19	chr12:1904001..1906826-chr12:1919472..1921344,2	K562	blood:
20	chr12:1915615..1917986-chr12:1924786..1926838,2	K562	blood:
21	chr12:1923072..1925795-chr12:1938699..1940589,2	MCF-7	breast:
22	chr12:1925102..1928805-chr12:1946979..1949915,3	MCF-7	breast:
23	chr12:1913786..1914380-chr7:76038925..76039444,2	HCT-116	colon:
24	chr12:1923163..1923961-chr12:1939620..1940160,2	MCF-7	breast:
25	chr12:1911026..1914378-chr12:2033211..2036733,3	MCF-7	breast:
26	chr12:1911095..1913405-chr12:2060628..2062758,2	MCF-7	breast:
27	chr12:1905333..1905883-chr12:1912952..1913884,2	K562	blood:
28	chr12:1930362..1931932-chr12:1934662..1936789,2	MCF-7	breast:

(count:15 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-LRTM2-5	chr12:1910051-1910116	NONHSAT025423
2	lnc-LRTM2-5	chr12:1916296-1916600	NONHSAT025423
3	lnc-LRTM2-5	chr12:1916296-1916651	NONHSAT025426
4	lnc-ADIPOR2-2	chr12:1929649-1929980	NONHSAT025427
5	lnc-ADIPOR2-2	chr12:1929738-1929980	NONHSAT025429
6	lnc-LRTM2-5	chr12:1917593-1917645	NONHSAT025423
7	lnc-LRTM2-5	chr12:1916296-1916651	NONHSAT025424
8	lnc-ADIPOR2-2	chr12:1929676-1929980	NONHSAT025428
9	lnc-ADIPOR2-2	chr12:1929750-1929980	NONHSAT025431
10	lnc-LRTM2-5	chr12:1910053-1910116	NONHSAT025426
11	lnc-LRTM2-5	chr12:1915457-1915724	NONHSAT025426
12	lnc-LRTM2-5	chr12:1910053-1910089	NONHSAT025425
13	lnc-LRTM2-5	chr12:1915457-1915724	NONHSAT025425
14	lnc-LRTM2-5	chr12:1916296-1916651	NONHSAT025425
15	lnc-LRTM2-5	chr12:1910051-1910089	NONHSAT025424

No data

Variant related genes	Relation type
CACNA2D4	TF binding region
LRTM2	TF binding region
CACNA2D4	CpG island
LRTM2	CpG island
ENSG00000146700	chromatin interactions
ENSG00000168003	chromatin interactions
ENSG00000151062	chromatin interactions
ENSG00000151065	chromatin interactions
ENSG00000203593	chromatin interactions
ENSG00000166159	chromatin interactions

Extended variants
information (count: 1206 )
Associated
traits (count: 82 )

Variant overlapped rSNPs/rCNVs (count:1206 , 50 per page) page: 1 2 3 4 5 6 7 ... 25

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs6489330	chr12:1907853-1907854	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs551824270	chr12:1907857-1907858	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs148258533	chr12:1907874-1907875	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs527929308	chr12:1907875-1907876	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs549158809	chr12:1907880-1907881	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs567431368	chr12:1907961-1907962	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs537903566	chr12:1907970-1907971	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs556543713	chr12:1907974-1907975	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs571517663	chr12:1908030-1908031	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs73043803	chr12:1908032-1908033	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs372775192	chr12:1908065-1908066	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs572366886	chr12:1908086-1908087	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs542882155	chr12:1908087-1908088	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs554762160	chr12:1908110-1908111	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs576205219	chr12:1908111-1908112	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs543121241	chr12:1908140-1908141	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs555767714	chr12:1908159-1908160	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs377223042	chr12:1908194-1908195	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs532042351	chr12:1908196-1908197	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs368989906	chr12:1908255-1908256	Weak transcription Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs560664627	chr12:1908257-1908258	Weak transcription Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs371548441	chr12:1908266-1908267	Weak transcription Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs7960114	chr12:1908273-1908274	Weak transcription Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
24	rs549170921	chr12:1908303-1908304	Weak transcription Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
25	rs567491624	chr12:1908340-1908341	Weak transcription Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
26	rs531708617	chr12:1908348-1908349	Weak transcription Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
27	rs550040420	chr12:1908365-1908366	Weak transcription Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs539454647	chr12:1908366-1908367	Weak transcription Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs117938259	chr12:1908373-1908374	Weak transcription Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs557628903	chr12:1908383-1908384	Weak transcription Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs184013281	chr12:1908415-1908416	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs758168	chr12:1908432-1908433	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
33	rs150806460	chr12:1908483-1908484	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs536502830	chr12:1908484-1908485	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs36032818	chr12:1908522-1908523	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs139492727	chr12:1908572-1908573	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs142785619	chr12:1908576-1908577	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs118166561	chr12:1908632-1908633	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs558417956	chr12:1908637-1908638	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs576864323	chr12:1908652-1908653	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs540681626	chr12:1908684-1908685	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs558877192	chr12:1908731-1908732	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs146080972	chr12:1908745-1908746	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs140079603	chr12:1908793-1908794	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs372494042	chr12:1908798-1908799	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs376967040	chr12:1908806-1908807	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs115192664	chr12:1908808-1908809	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs55971855	chr12:1908849-1908850	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs565275719	chr12:1908867-1908868	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs377755809	chr12:1908868-1908869	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:82)

Disease	PMID	Source
Myelofibrosis	22110671	CNVD
Non-syndromic sensorineural hearing loss	19587683	CNVD
Glaucoma	21310917	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Malignant peripheral nerve sheath tumor	19844265	CNVD
Squamous cell cancer	19607727	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Mental retardation	17847001	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
abnormal development	18461090	CNVD
Ovarian cancer	20844748	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Medulloblastoma	16968546	CNVD
Ovine squamous-cell carcinoma	17599052	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Breast cancer	22032731	CNVD
Cancer	21183584	CNVD
Myxofibrosarcoma	16751306	CNVD
Non-small cell lung cancer	21829676	CNVD
Ovarian neoplasms	16753589	CNVD
Prostate cancer	21965145	CNVD
Acute myeloid leukemia	16864856	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Disorders of sex development	21048976	CNVD
Glioblastoma multiforme	21080181	CNVD
Liposarcoma	21253554	CNVD
Prostate cancer	19156837	CNVD
Emphysema	19352772	CNVD
Medulloblastoma	21979893	CNVD
Basal cell lymphoma	17053054	CNVD
Malignant germ cell tumour	17285132	CNVD
Melanoma	18172304	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Wilms tumour	21544195	CNVD
Squamous cell cancer	21044232	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	19960244	CNVD
Endometrial cancer	22040021	CNVD
Colorectal cancer	20709793	CNVD
Breast cancer	21264507	CNVD
Cancer	16751803	CNVD
Testicular cancer	18059402	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Seminomas	18059402	CNVD
Esophageal cancer	21851588	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Testicular germ cell tumor	18059402	CNVD
Malaria	21533027	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
Breast cancer	21364760	CNVD
Acute lymphoblastic leukemia	21248843	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Ewing''s sarcoma	17952124	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	21858162	CNVD
Breast cancer	21509527	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21785460	CNVD
Ovarian cancer	21720365	CNVD
Myelodysplastic syndrome	21251322	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
small cell lung cancer	20016488	CNVD
Cancer	20164919	CNVD
Urothelial carcinoma	21177765	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:612 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr12:1905600-1928600	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
2	chr12:1905800-1913400	Weak transcription	HepG2	liver
3	chr12:1906000-1910000	Weak transcription	HSMM	muscle
4	chr12:1906400-1909800	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
5	chr12:1906400-1910400	Weak transcription	NH-A	brain
6	chr12:1906400-1913800	Weak transcription	Brain Angular Gyrus	brain
7	chr12:1906400-1913800	Weak transcription	Fetal Brain Male	brain
8	chr12:1906600-1908000	Weak transcription	Fetal Heart	heart
9	chr12:1906600-1909800	Weak transcription	Osteobl	bone
10	chr12:1906600-1910000	Weak transcription	Fetal Brain Female	brain
11	chr12:1906600-1910400	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
12	chr12:1906600-1913600	Weak transcription	Brain Anterior Caudate	brain
13	chr12:1906600-1913800	Weak transcription	Primary T cells from cord blood	blood
14	chr12:1906800-1909200	Weak transcription	NHDF-Ad	bronchial
15	chr12:1906800-1910000	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
16	chr12:1906800-1912800	Weak transcription	Skeletal Muscle Female	skeletal muscle
17	chr12:1906800-1913800	Weak transcription	Brain Cingulate Gyrus	brain
18	chr12:1906800-1913800	Weak transcription	Brain Inferior Temporal Lobe	brain
19	chr12:1906800-1913800	Weak transcription	Brain Substantia Nigra	brain
20	chr12:1906800-1914000	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
21	chr12:1906800-1914000	Weak transcription	Right Atrium	heart
22	chr12:1906800-1915400	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
23	chr12:1907000-1913800	Weak transcription	Primary T regulatory cells fromperipheralblood	blood
24	chr12:1907200-1909200	Weak transcription	Primary B cells from peripheral blood	blood
25	chr12:1907200-1909600	Weak transcription	Primary B cells from cord blood	blood
26	chr12:1907200-1909600	Weak transcription	Fetal Intestine Small	intestine
27	chr12:1907200-1910200	Weak transcription	Fetal Muscle Leg	muscle
28	chr12:1907200-1913000	Weak transcription	Right Ventricle	heart
29	chr12:1907200-1913400	Weak transcription	Duodenum Mucosa	Duodenum
30	chr12:1907200-1913800	Weak transcription	Primary T cells fromperipheralblood	blood
31	chr12:1907200-1913800	Weak transcription	Rectal Mucosa Donor 29	rectum
32	chr12:1907600-1908000	Weak transcription	Spleen	Spleen
33	chr12:1907600-1913600	Weak transcription	Primary neutrophils fromperipheralblood	blood
34	chr12:1907800-1908000	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
35	chr12:1907800-1909400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
36	chr12:1907800-1909400	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
37	chr12:1907800-1912800	Weak transcription	Skeletal Muscle Male	skeletal muscle
38	chr12:1907800-1913800	Weak transcription	Monocytes-CD14+_RO01746	blood
39	chr12:1908000-1908200	Enhancers	Spleen	Spleen
40	chr12:1908000-1910400	Enhancers	Fetal Heart	heart
41	chr12:1908200-1908400	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin01	Skin
42	chr12:1908200-1911600	Weak transcription	Spleen	Spleen
43	chr12:1909200-1910600	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
44	chr12:1909200-1910800	Enhancers	Primary B cells from peripheral blood	blood
45	chr12:1909200-1911600	Enhancers	NHDF-Ad	bronchial
46	chr12:1909400-1910000	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
47	chr12:1909400-1910000	Genic enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
48	chr12:1909400-1910400	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
49	chr12:1909600-1910800	Enhancers	Primary B cells from cord blood	blood
50	chr12:1909600-1911000	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links